Author:
Anderson Caitlin E.,Huynh Toan,Gasperino David J.,Alonzo Luis F.,Cantera Jason L.,Harston Stephen P.,Hsieh Helen V.,Marzan Rosemichelle,McGuire Shawn K.,Williford John R.,Oncina Ciela I.,Glukhova Veronika A.,Bishop Joshua D.,Cate David M.,Grant Benjamin D.,Nichols Kevin P.,Weigl Bernhard H.
Abstract
AbstractThe lateral flow assay (LFA) is one of the most popular technologies on the point-of-care diagnostics market due to its low cost and ease of use, with applications ranging from pregnancy to environmental toxins to infectious disease. While the use of these tests is relatively straightforward, significant development time and effort are required to create tests that are both sensitive and specific. Workflows to guide the LFA development process exist but moving from target selection to an LFA that is ready for field testing can be labor intensive, resource heavy, and time consuming. To reduce the cost and the duration of the LFA development process, we introduce a novel development platform centered on the flexibility, speed, and throughput of an automated robotic liquid handling system. The system comprises LFA-specific hardware and software that enable large optimization experiments with discrete and continuous variables such as antibody pair selection or reagent concentration. Initial validation of the platform was demonstrated during development of a malaria LFA but was readily expanded to encompass development of SARS-CoV-2 and Mycobacterium tuberculosis LFAs. The validity of the platform, where optimization experiments are run directly on LFAs rather than in solution, was based on a direct comparison between the robotic system and a more traditional ELISA-like method. By minimizing hands-on time, maximizing experiment size, and enabling improved reproducibility, the robotic system improved the quality and quantity of LFA assay development efforts.
Graphical abstract
Publisher
Springer Science and Business Media LLC
Subject
Biochemistry,Analytical Chemistry
Reference47 articles.
1. O’Farrell B. Evolution in lateral flow–based immunoassay systems. In: Lateral flow immunoassay. Totowa: Humana Press; 2009. p. 1–33.
2. Cuzzubbo AJ, Endy TP, Nisalak A, Kalayanarooj S, Vaughn DW, Ogata SA, et al. Use of recombinant envelope proteins for serological diagnosis of Dengue virus infection in an immunochromatographic assay. Clin Diagn Lab Immunol. 2001;8(6):1150–5.
3. Makler MT, Palmer CJ, Ager AL. A review of practical techniques for the diagnosis of malaria. Ann Trop Med Parasitol. 1998;92(4):419–33.
4. O’Farrell B. Chapter 2.4 - Lateral flow immunoassay systems: evolution from the current state of the art to the next generation of highly sensitive, quantitative rapid assays. In: The Immunoassay Handbook. 4th ed. Elsevier; 2013.
5. Fridley GE, Le H, Yager P. Highly sensitive immunoassay based on controlled rehydration of patterned reagents in a 2-dimensional paper network. Anal Chem. 2014;86(13):6447–53.
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献